Increased mitochondrial Ca2+ and decreased sarcoplasmic reticulum Ca2+ in mitochondrial myopathy

Human Molecular Genetics

Volumn 18, Issue 2, 2009, Pages 278-288

  Aydin, Jan ^a   Andersson, Daniel C ^a   Hänninen, Sandra L ^b   Wredenberg, Anna ^a   Tavi, Pasi ^a,b   Park, Chan Bae ^a   Nils Göran, Larsson ^a   Bruton, Joseph D ^a   Westerblad, Håkan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; CALSEQUESTRIN; CYCLOPHILIN D; CYCLOSPORIN A; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TFAM; UNCLASSIFIED DRUG; CALCIUM; CALCIUM BINDING PROTEIN; CASQ1 PROTEIN, MOUSE; DNA BINDING PROTEIN; HIGH MOBILITY GROUP PROTEIN; TFAM PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL DAMAGE; CELL METABOLISM; CELL STIMULATION; CONTROLLED STUDY; CYTOSOL; ENDOPLASMIC RETICULUM STRESS; GENE DISRUPTION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL MYOPATHY; MOUSE; MUSCLE CELL; MUSCLE CONTRACTION; MUSCLE FORCE; MUSCLE METABOLISM; MUSCLE WEAKNESS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; ANIMAL; GENETICS; HUMAN; METABOLISM; MITOCHONDRION; MOUSE MUTANT; SARCOPLASMIC RETICULUM; TRANSPORT AT THE CELLULAR LEVEL;

MUS;

ANIMALS; BIOLOGICAL TRANSPORT; CALCIUM; CALCIUM-BINDING PROTEINS; DNA-BINDING PROTEINS; HIGH MOBILITY GROUP PROTEINS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MITOCHONDRIAL MYOPATHIES; MUSCLE, SKELETAL; OXIDATIVE STRESS; SARCOPLASMIC RETICULUM;

EID: 58049192955     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddn355     Document Type: Article

References (60)

1. Larsson, N.G. and Oldfors, A. (2001) Mitochondrial myopathies. Acta Physiol. Scand., 171, 385-393.
2. Thorburn, D.R., Sugiana, C., Salemi, R., Kirby, D.M., Worgan, L., Ohtake, A. and Ryan, M.T. (2004) Biochemical and molecular diagnosis of mitochondrial respiratory chain disorders. Biochim. Biophys. Acta, 1659, 121-128.
3. Thorburn, D.R. (2004) Mitochondrial disorders: Prevalence, myths and advances. J. Inherit. Metab. Dis., 27, 349-362.
4. Schapira, A.H. (2006) Mitochondrial disease. Lancet, 368, 70-82.
5. Rossignol, R., Letellier, T., Malgat, M., Rocher, C. and Mazat, J.P. (2000) Tissue variation in the control of oxidative phosphorylation: implication for mitochondrial diseases. Biochem. J., 347, 45-53.
6. Wallace, D.C. (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annu. Rev. Genet., 39, 359-407.
7. Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J.N., Rovio, A.T., Bruder, C.E., Bohlooly, Y., Gidlof, S., Oldfors, A., Wibom, R. et al. (2004) Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature, 429, 417-423.
8. Kujoth, G.C., Hiona, A., Pugh, T.D., Someya, S., Panzer, K., Wohlgemuth, S.E., Hofer, T., Seo, A.Y., Sullivan, R., Jobling, W.A. et al. (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science, 309, 481-484.
9. Wredenberg, A., Wibom, R., Wilhelmsson, H., Graff, C., Wiener, H.H., Burden, S.J., Oldfors, A., Westerblad, H. and Larsson, N.G. (2002) Increased mitochondrial mass in mitochondrial myopathy mice. Proc. Natl Acad. Sci. USA, 99, 15066-15071.
10. Wredenberg, A., Freyer, C., Sandström, M.E., Katz, A., Wibom, R., Westerblad, H. and Larsson, N.G. (2006) Respiratory chain dysfunction in skeletal muscle does not cause insulin resistance. Biochem. Biophys. Res. Commun., 350, 202-207.
11. Falkenberg, M., Larsson, N.G. and Gustafsson, C.M. (2007) DNA replication and transcription in mammalian mitochondria. Annu. Rev. Biochem., 76, 679-699.
12. Tarnopolsky, M.A. and Raha, S. (2005) Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options. Med. Sci. Sports Exerc., 37, 2086-2093.
13. Allen, D.G., Lamb, G.D. and Westerblad, H. (2008) Skeletal muscle fatigue: Cellular mechanisms. Physiol. Rev., 88, 287-332.
14. 2+]i and force in skeletal muscle. Acta Physiol. Scand. 156, 407-416.
15. Wallace, D.C. (2001) Mouse models for mitochondrial disease. Am. J. Med. Genet., 106, 71-93.
16. Brookes, P.S., Yoon, Y., Robotham, J.L., Anders, M.W. and Sheu, S.S. (2004) Calcium, ATP, and ROS: A mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol., 287, C817-C833.
17. Allen, D.G. and Westerblad, H. (1995) The effects of caffeine on intracellular calcium, force and the rate of relaxation of mouse skeletal muscle. J. Physiol., 487, 331-342.
18. 2+ pump properties in frog skeletal muscle. J. Physiol., 441, 639-671.
19. Westerblad, H. and Allen, D.G. (1994) The role of sarcoplasmic reticulum in relaxation of mouse muscle; effects of 2,5-di(tert-butyl)-1,4-benzohyd roquinone. J. Physiol., 474, 291-301.
20. Esposito, L.A., Melov, S., Panov, A., Cottrell, B.A. and Wallace, D.C. (1999) Mitochondrial disease in mouse results in increased oxidative stress. Proc. Natl Acad. Sci. USA, 96, 4820-4825.
21. Turrens, J.F. (2003) Mitochondrial formation of reactive oxygen species. J. Physiol., 552, 335-344.
22. 2+ signals produced by osmotic stress in mouse skeletal muscle fibres. J. Physiol., 586, 197-210.
23. Fridovich, I. (1995) Superoxide radical and superoxide dismutases. Annu. Rev. Biochem., 64, 97-112.
24. McAdam, M.E., Levelle, F., Fox, R.A. and Fielden, E.M. (1977) A pulse-radiolysis study of the manganese-containing superoxide dismutase from Bacillus stearothermophilus. Biochem. J., 165, 81-87.
25. Hearn, A.S., Tu, C., Nick, H.S. and Silverman, D.N. (1999) Characterization of the product-inhibited complex in catalysis by human manganese superoxide dismutase. J. Biol. Chem., 274, 24457-24460.
26. Boveris, A., Oshino, N. and Chance, B. (1972) The cellular production of hydrogen peroxide. Biochem. J., 128, 617-630.
27. Murrant, C.L. and Reid, M.B. (2001) Detection of reactive oxygen and reactive nitrogen species in skeletal muscle. Microsc. Res. Tech., 55, 236-248.
28. St Pierre, J., Drori, S., Uldry, M., Silvaggi, J.M., Rhee, J., Jager, S., Handschin, C., Zheng, K., Lin, J., Yang, W. et al. (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell, 127, 397-408.
29. Aldini, G., Dalle-Donne, I., Facino, R.M., Milzani, A. and Carini, M. (2007) Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Med. Res. Rev., 27, 817-868.
30. 2+ in the regulation of energy metabolism. Dev. Neurosci., 15, 165-173.
31. Jouaville, L.S., Pinton, P., Bastianutto, C., Rutter, G.A. and Rizzuto, R. (1999) Regulation of mitochondrial ATP synthesis by calcium: Evidence for a long-term metabolic priming. Proc. Natl Acad. Sci. USA, 96, 13807-13812.
32. 2+ with recombinant targeted aequorin: significance for the regulation of pyruvate dehydrogenase activity. Proc. Natl Acad. Sci. USA, 93, 5489-5494.
33. 2+ in cell physiology and pathophysiology. Cell Calcium, 28, 339-348.
34. Madsen, K., Ertbjerg, P., Djurhuus, M.S. and Pedersen, P.K. (1996) Calcium content and respiratory control index of skeletal muscle mitochondria during exercise and recovery. Am. J. Physiol., 271 E1044-E1050.
35. Lännergren, J., Bruton, J.D. and Westerblad, H. (1999) Vacuole formation in fatigued single muscle fibres from frog and mouse. J. Muscle Res. Cell Motil., 20, 19-32.
36. 2+ detected with Rhod-2 in single frog and mouse skeletal muscle fibres during and after repeated tetanic contractions. J. Muscle Res. Cell Motil., 22, 265-275.
37. Bruton, J.D., Dahlstedt, A.J., Abbate, F. and Westerblad, H. (2003) Mitochondrial function in intact skeletal muscle fibres of creatine kinase deficient mice. J. Physiol., 552, 393-402.
38. Irwin, W.A., Bergamin, N., Sabatelli, P., Reggiani, C., Megighian, A., Merlini, L., Braghetta, P., Columbaro, M., Volpin, D., Bressan, G.M. et al. (2003) Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat. Genet., 35, 367-371.
39. Angelin, A., Tiepolo, T., Sabatelli, P., Grumati, P., Bergamin, N., Golfieri, C., Mattioli, E., Gualandi, F., Ferlini, A., Merlini, L. et al. (2007) Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins. Proc. Natl Acad. Sci. USA, 104, 991-996.
40. Merlini, L., Angelin, A., Tiepolo, T., Braghetta, P., Sabatelli, P., Zamparelli, A., Ferlini, A., Maraldi, N.M., Bonaldo, P. and Bernardi, P. (2008) Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies. Proc. Natl Acad. Sci. USA, 105, 5225-5229.
41. Park, C.B., Asin-Cayuela, J., Camara, Y., Shi, Y., Pellegrini, M., Gaspari, M., Wibom, R., Hultenby, K., Erdjument-Bromage, H., Tempst, P. et al. (2007) MTERF3 is a negative regulator of mammalian mtDNA transcription. Cell, 130, 273-285.
42. Beard, N.A., Laver, D.R. and Dulhunty, A.F. (2004) Calsequestrin and the calcium release channel of skeletal and cardiac muscle. Prog. Biophys. Mol. Biol., 85, 33-69.
43. Paolini, C., Quarta, M., Nori, A., Boncompagni, S., Canato, M., Volpe, P., Allen, P.D., Reggiani, C. and Protasi, F. (2007) Reorganized stores and impaired calcium handling in skeletal muscle of mice lacking calsequestrin-1. J. Physiol., 583, 767-784.
44. 2+ loads in lizard motor nerve terminals. J. Physiol., 509, 59-65.
45. 2+]. J. Neurosci., 19 7495-7506.
46. 2+ signals. EMBO J. 18, 4999-5008.
47. 2+] and secretion in chromaffin cells. Biochem. J., 365, 451-459.
48. 2+ elevation during agonist stimulation. J. Biol. Chem., 278, 10807-10815.
49. Baylor, S.M. and Hollingworth, S. (1988) Fura-2 calcium transients in frog skeletal muscle fibres. J. Physiol., 403, 151-192.
50. 2+]i during prolonged tetanic stimulation of intact, single fibres from mouse skeletal muscle. J. Physiol., 480, 31-43.
51. Goldenthal, M.J. and Marin-Garcia, J. (2004) Mitochondrial signaling pathways: A receiver/integrator organelle. Mol. Cell Biochem., 262, 1-16.
52. Biswas, G., Guha, M. and Avadhani, N.G. (2005) Mitochondria-to-nucleus stress signaling in mammalian cells: Nature of nuclear gene targets, transcription regulation, and induced resistance to apoptosis. Gene 354, 132-139.
53. Trifunovic, A., Hansson, A., Wredenberg, A., Rovio, A.T., Dufour, E., Khvorostov, I., Spelbrink, J.N., Wibom, R., Jacobs, H.T. and Larsson, N.G. (2005) Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc. Natl Acad. Sci. USA, 102, 17993-17998.
54. 2+ in single fibres from mouse limb muscles during repeated tetanic contractions. J. Physiol., 551, 179-190.
55. Millay, D.P., Sargent, M.A., Osinska, H., Baines, C.P., Barton, E.R., Vuagniaux, G., Sweeney, H.L., Robbins, J. and Molkentin, J.D. (2008) Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat. Med., 14, 442-447.
56. Bothe, G.W., Haspel, J.A., Smith, C.L., Wiener, H.H. and Burden, S.J. (2000) Selective expression of Cre recombinase in skeletal muscle fibers. Genesis, 26, 165-166.
57. Andrade, F.H., Reid, M.B., Allen, D.G. and Westerblad, H. (1998) Effect of hydrogen peroxide and dithiothreitol on contractile function of single skeletal muscle fibres from the mouse. J. Physiol., 509 565-575.
58. 2+ handling by phosphorylation status in mouse fast- and slow-twitch skeletal muscle fibers. Am. J. Physiol., 273, C1915-C1924.
59. 2+ influx for insulin-mediated glucose uptake in skeletal muscle. Diabetes, 55, 2077-2083.
60. Bruton, J.D., Place, N., Yamada, T., Silva, J.P., Andrade, F.H., Dahlstedt, A.J., Zhang, S.J., Katz, A., Larsson, N.G. and Westerblad, H. (2008) Reactive oxygen species and fatigue-induced prolonged low-frequency force depression in skeletal muscle fibres of rats, mice and SOD2 overexpressing mice. J. Physiol., 586, 175-184.